These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19868488)

  • 1. THERAPEUTIC ACTION OF N-PHENYLGLYCINEAMIDE-p-ARSONIC ACID (TRYPARSAMIDE) UPON EXPERIMENTAL INFECTIONS OF TRYPANOSOMA RHODESIENSE.
    Pearce L; Brown WH
    J Exp Med; 1921 Jan; 33(2):193-200. PubMed ID: 19868488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHEMOTHERAPY OF TRYPANOSOME AND SPIROCHETE INFECTIONS : BIOLOGICAL SERIES. III. THE THERAPEUTIC ACTION OF N-PHENYLGLYCINEAMIDE-p-ARSONIC ACID IN EXPERIMENTAL TRYPANOSOMIASIS OF RABBITS.
    Pearce L; Brown WH
    J Exp Med; 1919 Oct; 30(5):455-81. PubMed ID: 19868371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHEMOTHERAPY OF TRYPANOSOME AND SPIROCHETE INFECTIONS : BIOLOGICAL SERIES. I. THE TOXIC ACTION OF N-PHENYLGLYCINEAMIDE-p-ARSONIC ACID.
    Brown WH; Pearce L
    J Exp Med; 1919 Oct; 30(5):417-36. PubMed ID: 19868369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHEMOTHERAPY OF TRYPANOSOME AND SPIROCHETE INFECTIONS : BIOLOGICAL SERIES. II. THE THERAPEUTIC ACTION OF N-PHENYLGLYCINEAMIDE-p-ARSONIC ACID IN EXPERIMENTAL TRYPANOSOMIASIS OF MICE, RATS, AND GUINEA PIGS.
    Pearce L; Brown WH
    J Exp Med; 1919 Oct; 30(5):437-53. PubMed ID: 19868370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STUDIES ON THE TREATMENT OF HUMAN TRYPANOSOMIASIS WITH TRYPARSAMIDE (THE SODIUM SALT OF N-PHENYLGLYCINEAMIDE-p-ARSONIC ACID).
    Pearce L
    J Exp Med; 1921 Nov; 34(6 Suppl 1):1-104. PubMed ID: 19868583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHEMOTHERAPY OF TRYPANOSOME AND SPIROCHETE INFECTIONS : BIOLOGICAL SERIES. IV. THE ACTION OF N-PHENYLGLYCINEAMIDE-p-ARSONIC ACID UPON SPIROCHETE INFECTIONS.
    Brown WH; Pearce L
    J Exp Med; 1919 Oct; 30(5):483-96. PubMed ID: 19868372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THE INFLUENCE OF AGE AND OF DURATION OF TREATMENT ON THE PRODUCTION AND REPAIR OF BONE LESIONS IN EXPERIMENTAL HYPERPARATHYROIDISM.
    Jaffe HL; Bodansky A; Blair JE
    J Exp Med; 1932 Jan; 55(1):139-54. PubMed ID: 19869973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of Trypanosoma brucei, T. rhodesiense, and T. gambiense by the indirect fluorescent antibody test.
    Latif BM; Adam KM
    Bull World Health Organ; 1973; 48(4):401-7. PubMed ID: 4587481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent lack of a domestic animal reservoir in Gambiense sleeping sickness in northwest Uganda.
    Balyeidhusa AS; Kironde FA; Enyaru JC
    Vet Parasitol; 2012 Jun; 187(1-2):157-67. PubMed ID: 22245071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ETIOLOGY OF YELLOW FEVER : XII. CHEMOTHERAPY VERSUS SEROTHERAPY IN EXPERIMENTAL INFECTION WITH LEPTOSPIRA ICTEROIDES.
    Noguchi H
    J Exp Med; 1920 Sep; 32(4):381-400. PubMed ID: 19868452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of Trypanosoma gambiense and Trypanosoma rhodesiense infections in guinea pigs with nitrofurazone.
    EVENS F; NIEMEGEERS K; PACKCHANIAN A
    Am J Trop Med Hyg; 1957 Jul; 6(4):658-64. PubMed ID: 13458671
    [No Abstract]   [Full Text] [Related]  

  • 12. CHEMOTHERAPY OF TRYPANOSOME AND SPIROCHETE INFECTIONS : CHEMICAL SERIES. I. N-PHENYLGLYCINEAMIDE-p-ARSONIC ACID.
    Jacobs WA; Heidelberger M
    J Exp Med; 1919 Oct; 30(5):411-5. PubMed ID: 19868368
    [No Abstract]   [Full Text] [Related]  

  • 13. THE CHARACTER OF THE PNEUMONIC LESIONS PRODUCED BY INTRABRONCHIAL INSUFFLATION OF VIRULENT STREPTOCOCCI.
    Wollstein M; Meltzer SJ
    J Exp Med; 1913 Nov; 18(5):548-55. PubMed ID: 19867729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infections in mice with an irreversible inhibitor of S-adenosylmethionine decarboxylase.
    Bitonti AJ; Byers TL; Bush TL; Casara PJ; Bacchi CJ; Clarkson AB; McCann PP; Sjoerdsma A
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1485-90. PubMed ID: 1977366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of Grammomys surdaster thicket rats to Trypanosoma brucei gambiense infection.
    Büscher P; Bin Shamamba SK; Ngoyi DM; Pyana P; Baelmans R; Magnus E; Van Overmeir C
    Trop Med Int Health; 2005 Sep; 10(9):850-5. PubMed ID: 16135191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of the Trypanosoma brucei rhodesiense isolates from Tanzania using serum resistance associated gene as molecular marker.
    Kibona SN; Picozzi K; Matemba L; Lubega GW
    Tanzan Health Res Bull; 2007 Jan; 9(1):25-31. PubMed ID: 17547097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The curative power of 4-(2:6-diaminopyrimidin-4-ylamino) phenylarsine oxide (compound 12,065) in infections of Trypanosoma rhodesiense in laboratory animals.
    BAKER JR
    Br J Pharmacol Chemother; 1958 Dec; 13(4):436-9. PubMed ID: 13618549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosoma brucei: immunogenicity of the variant surface coat glycoprotein of virulent and avirulent subspecies.
    Diffley P
    Exp Parasitol; 1985 Feb; 59(1):98-107. PubMed ID: 3967729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An experimental analysis of the curative action of penicillin in acute bacterial infections. III. The effect of suppuration upon the antibacterial action of the drug.
    SMITH MR; WOOD WB
    J Exp Med; 1956 Apr; 103(4):509-22. PubMed ID: 13306859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [SLEEPING SICKNESS DUE TO TRYPANOSOMA RHODESIENSE IN RWANDA-BURUNDI].
    EVENS F
    Ann Soc Belg Med Trop (1920); 1963 Oct; 43():843-52. PubMed ID: 14122092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.